Market Cap
Bristol-Myers Squibb Company
$152.98 Billion
USD as of Jan. 1, 2023
Company | Market Cap (USD) |
---|---|
![]() |
$461.85 B |
![]() |
$347.61 B |
![]() |
$287.63 B |
![]() |
$285.80 B |
![]() |
$281.30 B |
Company | Market Cap (USD) |
---|---|
![]() |
$495.37 B |
![]() |
$461.85 B |
![]() |
$347.61 B |
![]() |
$304.61 B |
![]() |
$287.63 B |
Bristol Myers Squibb Company, also known as BMS, is a multinational pharmaceutical company. Tracing its origins to1858, it develops and manufactures prescription pharmaceuticals and biologics for a diverse range of diseases including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders.
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.